Literature DB >> 26026310

Non-pharmacological and pharmacological strategies of brown adipose tissue recruitment in humans.

Paul Lee1, Jerry R Greenfield2.   

Abstract

Humans maintain core temperature through a complex neuroendocrine circuitry, coupling environmental thermal and nutritional cues to heat-producing and dissipating mechanisms. Up to 40% of resting energy expenditure contributes to thermal homeostasis maintenance. Recent re-discovery of thermogenic brown adipose tissue (BAT) has brought the relation between ambient temperature, thermogenesis and systemic energy and substrate metabolism to the forefront. In addition to well-known pituitary-thyroid-adrenal axis, new endocrine signals, such as FGF21 and irisin, orchestrate crosstalk between white adipose tissue (WAT), BAT and muscle, tuning non-shivering and shivering thermogenesis responses. Cold exposure modulates the endocrine milieu, and cold-induced hormones cause bioenergetics transformation sufficient to impact whole body metabolism. This review will appraise the nature of human BAT and the basis of BAT-centred therapeutics, highlighting how the interaction between hormones and adipose tissue impacts metabolic responses. Non-pharmacological and pharmacological strategies of BAT recruitment and/or fat browning for metabolic benefits will be discussed.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Beige adipose tissue; Energy balance; FGF21; Irisin; Metabolism; Thermogenesis

Mesh:

Substances:

Year:  2015        PMID: 26026310     DOI: 10.1016/j.mce.2015.05.025

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  15 in total

1.  Kinase Inactive Tyrosine Kinase (Tyk2) Supports Differentiation of Brown Fat Cells.

Authors:  Vidisha Raje; Marta Derecka; Marc Cantwell; Jeremy Meier; Karol Szczepanek; Jennifer D Sisler; Birgit Strobl; Ana Gamero; Thurl E Harris; Andrew C Larner
Journal:  Endocrinology       Date:  2017-01-01       Impact factor: 4.736

2.  Lipopolysaccharide-binding protein is a negative regulator of adipose tissue browning in mice and humans.

Authors:  Aleix Gavaldà-Navarro; José M Moreno-Navarrete; Tania Quesada-López; Montserrat Cairó; Marta Giralt; José M Fernández-Real; Francesc Villarroya
Journal:  Diabetologia       Date:  2016-06-25       Impact factor: 10.122

3.  Depot-specific UCP1 expression in human white adipose tissue and its association with obesity-related markers.

Authors:  Hye Soon Park; Yeon Jin Jang; Jisun Lim; Jimin Kim; Jong-Hyeok Kim; YeonJi Lee; Yoonseok Heo
Journal:  Int J Obes (Lond)       Date:  2020-01-21       Impact factor: 5.095

Review 4.  Brown and Beige Adipose Tissue: Therapy for Obesity and Its Comorbidities?

Authors:  Anny Mulya; John P Kirwan
Journal:  Endocrinol Metab Clin North Am       Date:  2016-09       Impact factor: 4.741

5.  Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia.

Authors:  Hana Malinská; Martina Hüttl; Denisa Miklánková; Jaroslava Trnovská; Iveta Zapletalová; Martin Poruba; Irena Marková
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

6.  Meeting report of the 2016 bone marrow adiposity meeting.

Authors:  Bram van der Eerden; André van Wijnen
Journal:  Adipocyte       Date:  2017-04-14       Impact factor: 4.534

7.  Estrogen-Related Receptors Mediate the Adaptive Response of Brown Adipose Tissue to Adrenergic Stimulation.

Authors:  Erin L Brown; Bethany C Hazen; Elodie Eury; Jean-Sébastien Wattez; Marin L Gantner; Verena Albert; Sarah Chau; Manuel Sanchez-Alavez; Bruno Conti; Anastasia Kralli
Journal:  iScience       Date:  2018-04-27

8.  Thyroid hormone acting via TRβ induces expression of browning genes in mouse bone marrow adipose tissue.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Endocrine       Date:  2017-02-22       Impact factor: 3.633

Review 9.  Classification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and Obesity.

Authors:  Jogeshwar Mukherjee; Aparna Baranwal; Kimberly N Schade
Journal:  Curr Diabetes Rev       Date:  2016

10.  Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice.

Authors:  Longwei Zhao; Huiyan Wang; Junjun Xie; Zilu Chen; Xiaokun Li; Jianlou Niu
Journal:  BMC Biotechnol       Date:  2017-07-04       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.